Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Roberts to market Lodine in U.K. and Ireland

Jan. 8, 1997

No Comments

Neurobiological Technologies discontinues development of antiarthritic agent

Jan. 8, 1997

No Comments

Anti-gp130 MAbs for inflammatory disorders and myeloma

Jan. 2, 1997

No Comments

British researchers describe anticytokine antisense peptides

Dec. 30, 1996

No Comments

Biomatrix-Boehringer Ingelheim Synvisc agreement

Dec. 23, 1996

No Comments

ConXn effective in lung fibrosis

Dec. 20, 1996

No Comments

GLA effective in treating active rheumatoid arthritis

Dec. 18, 1996

No Comments

Anti-L-selectin aptamers demonstrate efficacy in animals

Dec. 18, 1996

No Comments

ML-3000 progresses through the pipeline

Dec. 18, 1996

No Comments

Antiinflammatory glycolipid compounds from Nissin Food Products

Dec. 16, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Musculoskeletal
RSS

Roberts to market Lodine in U.K. and Ireland

Neurobiological Technologies discontinues development of antiarthritic agent

Anti-gp130 MAbs for inflammatory disorders and myeloma

British researchers describe anticytokine antisense peptides

Biomatrix-Boehringer Ingelheim Synvisc agreement

ConXn effective in lung fibrosis

GLA effective in treating active rheumatoid arthritis

Anti-L-selectin aptamers demonstrate efficacy in animals

ML-3000 progresses through the pipeline

Antiinflammatory glycolipid compounds from Nissin Food Products

Today's news in brief

Today's news in brief

Second insulin receptor offers new therapeutic avenues

KITE-753, a rapid manufactured CAR T therapy with superior antitumor efficacy and enhanced expansion in vivo

Boryung invests $10M in Intuitive Machines for outer space R&D

Musculoskeletal RSS

Musculoskeletal
RSS